USING RESULTS OF FIRST-TRIMESTER BIOCHEMICAL SCREENING AND UTERINE ARTERY PULSATILITY INDEX FOR INCLUSION IN RISK GROUPS FOR FETAL GROWTH RESTRICTION
https://doi.org/10.21518/2079-701X-2017-2-52-56
Abstract
Objective: to study the combined use of first-trimester biochemical screening results and uterine artery pulsality index (PI) for inclusion in risk group for fetal growth restriction (FGR), improvement of pregnancy outcomes in women from the risk group for the development of FGR.
Material and methods. The work is based on the results of studies conducted from 2009 to 2014 in the maternity unit of Republican Clinical Hospital № 2 MoH in the Republic of Tatarstan which is the clinical facility for the Department of Obstetrics and Gynecology № 1 of the Continuing Medical Education Institution “Kazan State Medical University” MoH RF, and maternity unit and prenatal clinic of the Volzhskaya Central City Hospital in the Mari El Republic. First-trimester biochemical screening results and uterine artery PI were the basis for the formation of FGR risk groups. Pregnancy and delivery outcomes in 156 pregnant women with a risk for the development of FGR and in 25 healthy controls were evaluated. In order to improve the placental blood flow based on the proven safety profile, all women with FGR received dipyridamole in the II trimester of pregnancy for at least 3 weeks.
Conclusion: concomitant decrease in PAPP-A MoM and increase in uterine artery PI provide the most valuable information for forecasting FGR. Administration of dipyridamole by women with FGR helps to improve placental blood flow, prevents degenerative changes in the placenta, and promotes live births even in III degree FGR.
About the Authors
R. S. Zamaleeva
Kazan State Medical Academy
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
N. A. Cherepanova
Kazan State Medical Academy
Russian Federation
PhD in Medicine
Russian Federation
PhD in Medicine
D. V. Frizin
Kazan State Medical Academy
Russian Federation
PhD in Medicine
Russian Federation
PhD in Medicine
A. V. Frizina
Kazan State Medical Academy
Russian Federation
Russian Federation
References
1. Макаров И.О., Юдина Е.В., Боровкова Е.И., Байрамова М.А., Кирпикова Е.И. Биохимический скрининг для прогнозирования неблагоприятных исходов беременности. Вопросы гинекологии, акушерства и перинатологии, 2011, 2(10): 62-67.
2. Стрижаков А.Н., Игнатко И.В., Давыдов А.И., Тимохина Е.В., Карданова М.А., Мирющенко М.М. Прогнозирование и ранняя диагностика синдрома задержки роста плода. Вопросы гинекологии, акушерства и перинатологии, 2014, 13(4): 5-11.
3. Reddy UM et al. Prepregnancy risk factops for antepartum stillbirth in the United States. Obstet. Gynecol., 2010, 116(5): 1119-1126.
4. Иозефсон С.А., Белозерцева Е.П., Белокриницкая Т.Е., Салимова М.Д., Федорова Е.А. Анализ течения беременности у женщин с антенатальной гибелью плода. Мать и Дитя в Кузбассе, 2015, 1(60): 55-58.
5. Серов В.Н. Синдром задержки развития плода. РМЖ, 2005, 13(1): 31-33.
6. Радзинский В.Е. Акушерская агрессия. М.: Издательство журнала Status Praesens, 2011. 688 c.
7. Гинзбург Б.Г. Задержка роста плода и постнатальная патология. Проблемы репродукции, 2011, 17(5): 90-95.
8. Милованов А.П., Кирющенков П.А., Шмаков Р.Г. Плацента – регулятор гемостаза матери. Акушерство и гинекология, 2001, 3: 3-5.
9. Макаров И.О., Шешукова Н.А. Профилактика и терапия фетоплацентарной недостаточности у беременных с привычной потерей беременности. Гинекология, 2011, 3: 3-6.
10. Poon LC, Stratieva V, Piras S et al. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn, 2010, 30(3): 216-223.
11. Савельева Г.М., Бугеренко Е.Ю., Панина О.Б. Прогностическая значимость нарушения маточно-плацентарного кровообращения в I триместре беременности у пациенток с отягощенным акушерским анамнезом. Вестник РАМН, 2013, 7: 4-8.
12. Pilalis A, Souka AP, Antsaklis P et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks gestation. Ultrasound Obstet. Gynecol., 2007, 29: 135-140.
13. Poon LC, Maiz N, Valencia C et al. Firsttrimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet. Gynecol., 2009, 33(1): 23-33.
14. Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat. Diagn., 2008, 28: 7-10.
15. Петрухин В.А., Гурьев В.М., Павлова Т.В., Ртишева А.В. Плацентарная недостаточность у беременных с артериальной гипертензией и возможности ее коррекции. Российский вестник акушера-гинеколога, 2011, 5: 81-84.
Review
For citations:
Zamaleeva RS, Cherepanova NA, Frizin DV, Frizina AV. USING RESULTS OF FIRST-TRIMESTER BIOCHEMICAL SCREENING AND UTERINE ARTERY PULSATILITY INDEX FOR INCLUSION IN RISK GROUPS FOR FETAL GROWTH RESTRICTION. Meditsinskiy sovet = Medical Council. 2017;(2):52-56. (In Russ.) https://doi.org/10.21518/2079-701X-2017-2-52-56
Views:
908
Email this article 